Work

Abstract A112: A first in class immunotherapy that selectively activates the NFAT pathway in CD8+ T cells

Year: 2025

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2025-a112

Authors: Eric Lazear, Dan Watkins, Alexander Krupnick, John Westwick

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407866539

Cites:

Cited by:

Related to: 10